Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
197.08
-0.02 (-0.01%)
Official Closing Price
Updated: 7:00 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Charles River Laboratories Intl
< Previous
1
2
3
4
Next >
The 3 Most Undervalued Tech Stocks to Buy Now: November 2023
November 17, 2023
Growth stocks are rallying but there are still bargains to be found. These three top tech picks can reward long-term investors.
Via
InvestorPlace
Expert Ratings for Charles River
November 10, 2023
Via
Benzinga
Charles River Labs Q3 Revenue Jumps 4% Despite Softer Client Spending, Narrows Outlook
November 08, 2023
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the
Via
Benzinga
8 Analysts Have This to Say About Charles River
October 24, 2023
Via
Benzinga
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
October 05, 2023
S&P 500 stocks are sliding amid a worrying interest rate environment. However, these three can buck the current downtrend.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 21, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via
Benzinga
What 5 Analyst Ratings Have To Say About Charles River
September 13, 2023
Via
Benzinga
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
September 06, 2023
VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead.
Via
InvestorPlace
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
August 25, 2023
Wall Street Journal
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection
August 25, 2023
Charles River Laboratories International Inc (NYSE: CRL) has joined hands with four significant entities in a pioneering move to amplify protections for the horseshoe crabs and the red knots bird...
Via
Benzinga
4 Analysts Have This to Say About Charles River
July 10, 2023
Via
Benzinga
Charles River: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Will Chart Analysts Notice Bad Omen on Charles River's Chart
April 13, 2023
Via
Benzinga
B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know
August 10, 2023
Via
Benzinga
US Stocks Edge Lower; Charles River Earnings Top Estimates
August 09, 2023
U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the...
Via
Benzinga
Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday
August 09, 2023
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks
August 09, 2023
The CNN Money Fear and Greed index showed a decline in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed lower on Tuesday after Moody's downgraded the credit ratings of several US...
Via
Benzinga
Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
August 02, 2023
Explore the resilience of healthcare stocks that are demonstrating signs of recovery, with robust long-term growth potential ahead.
Via
InvestorPlace
Analyst Ratings for Charles River
March 28, 2023
Via
Benzinga
Why Charles River Stock Is Plunging Today
February 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
July 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 10, 2023
July 10, 2023
Via
Benzinga
BlackRock To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
July 10, 2023
Keybanc raised the price target for BILL Holdings, Inc. (NYSE: BILL) from $110 to $140. Keybanc analyst Josh Beck maintained an Overweight rating. BILL Holdings shares fell 2.3% to $113.00 in...
Via
Benzinga
3 Cheap Stocks to Buy Before They Bounce Back
July 04, 2023
Afraid of missing out on the big market rally? These three cheap stocks to buy are still strong options, so hop on board.
Via
InvestorPlace
3 Long-term Healthcare Stocks to Add to Your Portfolio
June 14, 2023
These long-term healthcare stocks should benefit from the global surge in spending for life-improving pharmaceutical drugs, therapies, and medical devices.
Via
InvestorPlace
3 DNA Stocks to Buy for the Synthetic Biology Revolution
May 14, 2023
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.
Via
InvestorPlace
3 Healthcare Stocks With Huge Growth Potential
April 24, 2023
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.
Via
InvestorPlace
$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
February 27, 2023
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
February 23, 2023
Via
Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 22, 2023
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.